These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35509416)

  • 21. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Mc Ardle R; Galna B; Donaghy P; Thomas A; Rochester L
    Alzheimers Dement; 2019 Oct; 15(10):1367-1377. PubMed ID: 31548122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
    Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z
    BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of arterial stiffness with cognition in patients with Lewy body disorder.
    Ryu DW; Kim JS; Lee JE; Park JW; Oh YS; An JY; Lee KS
    Neurol Sci; 2017 Jul; 38(7):1307-1313. PubMed ID: 28474150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological performance in Lewy body dementia and Alzheimer's disease.
    Walker Z; Allen RL; Shergill S; Katona CL
    Br J Psychiatry; 1997 Feb; 170():156-8. PubMed ID: 9093505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
    Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
    JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apathy in Lewy body disease and its effects on functional impairment over time.
    Zhu CW; Grossman HT; Elder GA; Rosen H; Sano M
    Front Neurol; 2024; 15():1339190. PubMed ID: 38313558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
    Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectories and Determinants of Quality of Life in Dementia with Lewy Bodies and Alzheimer's Disease.
    van de Beek M; van Steenoven I; Ramakers IHGB; Aalten P; Koek HL; Olde Rikkert MGM; Manniën J; Papma JM; de Jong FJ; Lemstra AW; van der Flier WM
    J Alzheimers Dis; 2019; 70(2):389-397. PubMed ID: 31177218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity and reliability of the Turkish version of the ALBA screening instrument for Lewy body dementia in older adults.
    Kaya D; Yesil Gurel BH; Akpinar Soylemez B; Dost FS; Dokuzlar O; Mutlay F; Ates Bulut E; Petek K; Golimstok AB; Isik AT
    Appl Neuropsychol Adult; 2022 Nov; ():1-6. PubMed ID: 36332080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energy intake and expenditure in patients with Alzheimer's disease and mild cognitive impairment: the NUDAD project.
    Doorduijn AS; de van der Schueren MAE; van de Rest O; de Leeuw FA; Hendriksen HMA; Teunissen CE; Scheltens P; van der Flier WM; Visser M
    Alzheimers Res Ther; 2020 Sep; 12(1):116. PubMed ID: 32979927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases.
    Barba L; Bellomo G; Oeckl P; Chiasserini D; Gaetani L; Torrigiani EG; Paoletti FP; Steinacker P; Abu-Rumeileh S; Parnetti L; Otto M
    J Neurol Sci; 2024 Jul; 462():123059. PubMed ID: 38850771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
    Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
    J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of neuropathology with cognitive decline among older persons without dementia.
    Boyle PA; Yu L; Wilson RS; Schneider JA; Bennett DA
    Front Aging Neurosci; 2013; 5():50. PubMed ID: 24058343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Components of the choline oxidation pathway modify the association between the apolipoprotein ε4 gene variant and cognitive decline in patients with dementia.
    Hildre AS; Solvang SH; Aarsland D; Midtun Ø; McCann A; Ervik AO; Nygård O; Ueland PM; Nordrehaug JE; Giil LM
    Brain Res; 2020 Jan; 1726():146519. PubMed ID: 31654640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
    Jellinger KA
    J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study.
    Rongve A; Soennesyn H; Skogseth R; Oesterhus R; Hortobágyi T; Ballard C; Auestad BH; Aarsland D
    BMJ Open; 2016 Feb; 6(2):e010357. PubMed ID: 26928028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.